Page 128 - 74_02

A. BONORA-CENTELLES Y COLS. AN. R. ACAD. NAC. FARM.

(12) DONATO, M. T.; LAHOZ, A.; JIMÉNEZ, N.; PÉREZ, G.; SERRALTA, A.; MIR, J.; CASTELL,
J. V. y GÓMEZ-LECHÓN, M. J. (2006): Potential impact of steatosis on cytochro-
(13) me P450 enzymes of human hepatocytes isolated from fatty liver grafts. Drug
(14) metabolism and Dispositions. 34: 1556-1562.
(15) GÓMEZ-LECHÓN, M. J.; DONATO, T.; CASTELL, J. V. y JOVER, R. (2004): Human
(16) hepatocytes in primary culture: the choice to investigate drug metabolism in
(17) man. Current Drug. Metab. 5: 443-462.
LEKSTROM-HIMES, J. y XANTHOPOULOS, K. G. (1998): Biological role of the
(18) CCAAT/enhancer-binding protein family of transcription factors. J. Biol.
(19) Chem. 273: 28545-28548.
(20) LI, J.; NING, G. y DUNCAN, S. A. (2000): Mammalian hepatocyte differentiation
(21) requires the transcription factor HNF-4alpha. Genes Dev. 14: 464-474.
(22) JOVER, R. (2004): Control génico de la expresión del citocromo P-450 en el
hígado. En: Citocromo P-450 (Cascales-Angosto, M. y Gómez-Lechón, M. J.,
(23) Eds.), pp. 205-239. Realigraf, S. A. Press, Madrid, Spain.
GEBHARDT, R.; HENGSTLER, J. G.; MULLER, D.; GLOCKNER, R.; BUENNING, P.; LAUBE,
(24) B.; SCHMELZER, E.; ULLRICH, M.; UTESCH, D.; HEWITT, N.; RINGEL, M.; HILZ, B. R.;
(25) BADER, A.; LANGSCH, A.; KOOSE, T.; BURGER, H. J.; MAAS, J. y OESCH, F. (2003):
New hepatocyte in vitro systems for drug metabolism: metabolic capacity
and recommendations for application in basic research and drug develop-
ment, standard operation procedures. Drug Metab. Rev. 35: 145-213.
BANAS, A.; TERATANI, T.; YAMAMOTO, Y.; TOKUHARA, M.; TAKESHITA, F.; QUINN, G.;
OKOCHI, H. y OCHIYA, T. (2007): Adipose Tissue-derived mesenchymal stem
cells as a source of human hepatocytes. Hepatology. 46: 219-228.
SEO, M. J.; SUH, S. Y.; BAE, Y. C. y JUNG, J. S. (2005): Differentiation of human
adipose stromal cells into hepatic lineage in vitro and in vivo. BBRC. 328:
258-264.
SCHWARTZ, R. E.; REYES, M.; KOODIE, L.; JIANG, Y.; BLACKSTAD, M. and LUND, T.
(2002): Multipotent adult progenitor cells from bone marrow differentiate
into functional hepatocyte-like cells. J. Clin. Invest. 109: 1291-1302.
JUNG, J.; ZHENG, M.; GOLDFARB, M. and ZARET, K. S. (1999): Initiation of
mammalian liver development from endoderm by fibroblast growth factors.
Science. 284: 1998-2003.
ROSSI, J. M.; DUNN, N. R.; HOGAN, L. M. and ZARET, K. S. (2001): Distinct
mesodermal signals, including BMPs from the septum transversum mesen-
chyme, are required in combination for hepatogenesis from the endoderm.
Genes & Development. 15: 1998-2009.
GÓMEZ-LECHÓN, M. J.; CASTELL, J.; GUILLEN, I.; O’CONNOR, E.; NAKAMURA, T.;
FABRA, R. and TRULLENQUE, R. (1995): Effects of hepatocyte growth factor on
the growth and metabolism of human hepatocytes in primary culture. Hepa-
tology. 21: 1248-1254.
MIYAJIMA, A.; KINOSHITA, T.; TANAKA, M.; KAMIYA, A.; MUKOUYAMA, Y. and HARA,
T. (2000): Role of oncostatin M in hematopoyesis and liver development.
Cytokines & Growth Factors Reviews. 11: 177-183.
HAYNESWORTH, S. E.; BABER, M. A. y CAPLAN, A. I. (1992): Cell surface antigens
on human marrow-derived mesenchymal cells are detected by monoclonal
antibodies. Bone. 13: 69-80.

306